GLOBUS MEDICAL INC. CLASS A overview

NuVasive Shareholders Approve Merger Agreement with Globus Medical PR Newswire SAN DIEGO, April 27, 2023 SAN DIEGO , April 27, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the Company's merger agreement with Globus...

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical PR Newswire SAN DIEGO, April 17, 2023 SAN DIEGO , April 17, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that proxy advisory firm, Glass Lewis & Co., LLC ("Glass Lewis"), recommends...

Leading Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical PR Newswire SAN DIEGO, April 14, 2023 SAN DIEGO , April 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that leading independent proxy advisory firm Institutional Shareholder Services ("ISS") recommends...

Shareholder Alert: Ademi LLP investigates whether NuVasive, Inc. has obtained a Fair Price in its transaction with Globus Medical PR Newswire MILWAUKEE, Feb. 9, 2023 MILWAUKEE , Feb. 9, 2023 /PRNewswire/ -- Ademi LLP is investigating NuVasive (NASDAQ: NUVA) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical. Click here to learn how to join the action https://www.ademilaw.com/case/nuvasive-inc or call Guri Ademi toll-free at 866-264-3995....

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Globus Medical, Inc. (NYSE: GMED) and NuVasive, Inc. is fair to Globus shareholders. Under the terms of the merger agreement, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock. Halper Sadeh encourages Globus shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at...

Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care PR Newswire AUDUBON, Pa. and SAN DIEGO, Feb. 9, 2023 Capitalizes on complementary global commercial organizations and accelerates Globus Medical's and NuVasive's globalization strategies to increase customer reach and deepen surgeon relationships Brings together innovative technologies to create comprehensive procedural solutions offering to better support...

NEW YORK, NY / ACCESSWIRE / February 21, 2018 / Globus Medical, Inc. Class A (NYSE: GMED ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018, at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/1690 . To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor...